Nureca Ltd
Wed 21/05/2025,15:15:24 | NSE : NURECA
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 247.00
Previous Close
₹ 246.30
Volume
2583
Mkt Cap ( Rs. Cr)
₹251.22
High
₹ 251.22
Low
₹ 247.00
52 Week High
₹ 447.50
52 Week Low
₹ 203.62
Book Value Per Share
₹ 194.30
Dividend Yield
0.00
Face Value
₹ 10.00
What’s Your Call?
Collective community sentiment on Nureca Ltd
Your Vote -
Buy
35.90%
Hold
3.42%
Sell
60.68%
35.90%
117 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
100%
Sell Order Quantity
0%
Bid Price
Qty
207.99
23
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
23
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Nureca Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Nureca Ltd - Announcement Under Regulation 30
-
Nureca Ltd - Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations\r\nAnd Disc
-
Nureca Ltd - Copy of Newspaper Publication
-
Nureca Ltd - Record Date
-
Nureca Ltd - Outcome of Board Meeting
-
Nureca Ltd - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
-
Nureca Ltd - Appointment
-
Nureca Ltd - Announcement under Regulation 30 (LODR)-Resignation of Director
-
Nureca Ltd - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
-
Nureca Ltd - Announcement under Regulation 30 (LODR)-Cessation
-
Nureca Ltd - Resignation
-
Nureca Ltd - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
-
Nureca Ltd - Book Closure
-
Nureca Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Nureca Ltd - Press Release
-
Nureca Ltd - Announcement under Regulation 30 (LODR)-Investor Presentation
-
Nureca Ltd - General Updates
-
Nureca Ltd posts Q4 net profit of Rs 2.07 cr
-
Nureca Ltd - Board Meeting Outcome for OUTCOME OF BOARD MEETING HELD ON 05 MAY 2025
-
Nureca Ltd - Outcome of Board Meeting
-
Nureca Ltd - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
-
Nureca Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Nureca Ltd - Press Release
-
Nureca Ltd - Business Update
-
Nureca Ltd - General Updates
-
Nureca Ltd - Board Meeting Intimation for Consider And Approve, Inter-Alia, The Audited Financial Results\r\n(Standalone And
-
Nureca Ltd - Board Meeting Intimation
-
Nureca Ltd - General Updates
-
Nureca Ltd - Nureca Limited Has Informed The Exchange Regarding Business Update .
-
Nureca Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025
-
Nureca Ltd - General Updates
-
Nureca Ltd - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Nureca Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Nureca Ltd - Business Update
-
Nureca Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Nureca Ltd - Press Release
-
Nureca Ltd - Shareholders meeting
-
Nureca Ltd - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report
-
Nureca Ltd - Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regu
-
Nureca Ltd - Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading )Regu
-
Nureca Ltd - Trading Window-XBRL
-
Nureca Ltd - Trading Window
-
Nureca Ltd - Updates
-
Nureca Ltd - Updates
-
Nureca Ltd - Updates
-
Nureca Ltd - Updates
-
Nureca Ltd - Nureca Limited Has Informed The Exchange Regarding 'Nureca Limited Has Informed The Exchange Regarding 'Disclo
-
Nureca Ltd - Nureca Limited Has Informed The Exchange Regarding 'Nureca Limited Has Informed The Exchange Regarding 'Disclo
-
Nureca Ltd - Nureca Limited Has Informed The Exchange Regarding 'Nureca Limited Has Informed The Exchange Regarding 'Disclo
-
Nureca Ltd - Nureca Limited Has Informed The Exchange Regarding 'Nureca Limited Has Informed The Exchange Regarding 'Disclo
-
Nureca Ltd - Nureca Limited Has Informed The Exchange Regarding 'Nureca Limited Has Informed The Exchange Regarding 'Disclo
-
Nureca Ltd - Updates
-
Nureca Ltd - Nureca Limited Has Informed The Exchange Regarding Revised Disclosure Under Regulation 7(2) Of Securities And Ex
-
Nureca Ltd - Nureca Limited Has Informed The Exchange Regarding 'Disclosure Under Regulation 7(2) Of Securities And Exchange
-
Nureca Ltd - Updates
-
Nureca Ltd - Nureca Limited Has Informed The Exchange Regarding 'Disclosure Under Regulation 7(2) Of Securities And Exchange
-
Nureca Ltd - Nureca Limited Has Informed The Exchange Regarding 'Disclosure Under Regulation 7(2) Of Securities And Exchange
-
Nureca Ltd - Nureca Limited Has Informed The Exchange Regarding 'Disclosure Under Regulation 7(2) Of Securities And Exchange
-
Nureca Ltd - Nureca Limited Has Informed The Exchange Regarding 'Disclosure Under Regulation 7(2) Of Securities And Exchange
-
Nureca Ltd - Copy of Newspaper Publication
-
Nureca Ltd - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
-
Nureca Ltd - Notice Of Shareholders Meetings-XBRL
-
Nureca Ltd - Shareholders meeting
-
Nureca Ltd - Outcome of Board Meeting
-
Nureca Ltd - Outcome of Board Meeting
-
Nureca Ltd - Outcome Of Board Meeting Under Regulation 30 Of SEBI (LODR)Regulations,2015
-
Nureca hit 5% upper circuit
Key fundamentals
Evaluate the intrinsic value of Nureca Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | March-21 |
|---|---|---|---|---|---|
| Assets | 194.002 | 193.261 | 195.263 | 203.743 | 166.774 |
| Liabilities | 194.002 | 193.261 | 195.263 | 203.743 | 166.774 |
| Equity | 10 | 10 | 10 | 10 | 10 |
| Gross Profit | -9.732 | -11.131 | -15.39 | 55.773 | 61.682 |
| Net Profit | -0.668 | -2.442 | -8.422 | 45.309 | 46.534 |
| Cash From Operating Activities | -18.548 | -2.997 | 12.051 | 1.827 | 35.101 |
| NPM(%) | -0.58 | -2.58 | -7.52 | 17.73 | 21.81 |
| Revenue | 114.64 | 94.521 | 111.899 | 255.549 | 213.331 |
| Expenses | 124.372 | 105.652 | 127.289 | 199.776 | 151.649 |
| ROE(%) | -0.34 | -1.25 | -4.33 | 23.31 | 23.94 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|---|---|---|---|
| 24 Feb 2022 | 3 | 30 | 0 | 1489.5 |
| 21 Sep 2021 | 2 | 20 | 0 | 1546.25 |
Peers
Other companies within the same industry or sector that are comparable to Nureca Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Procter and Gamble Hygiene and Healthcare Ltd | 14187.00 | -0.47 | 64.33 | 798.52 | 2079.50 | 1.80 |
| Godrej Industries Ltd | 1160.40 | 0.30 | 39.82 | 8282.82 | 2914.25 | 0.00 |
| Colgate-Palmolive (India) Ltd | 2659.30 | 1.14 | 49.48 | 6690.86 | 4866.65 | 2.18 |
| Shanthala FMCG Products Ltd | 27.85 | 0.00 | 32.01 | 164.77 | 4.39 | 0.00 |
Company Info
The Company was incorporated as `Nureca Private Limited', as a private limited company, under the Companies Act, 2013 on November 2, 2016 and a certificate of incorporation was issued by Registrar of Companies, Central Registration Centre, at Delhi. The registered office of the Company was changed from Delhi to Mumbai, Maharashtra, pursuant to certificate of registration of regional director order dated January 8, 2019 for change of state issued by the RoC with effect from February 8, 2019. Upon to conversion into a public limited company pursuant to a special resolution passed in the extra ordinary general meeting of the shareholders of the Company held on June 19, 2020, the name of the Company was changed to the present name `Nureca Limited' and a fresh certificate of incorporation was issued by the RoC on July 8, 2020.The Company became a wholly owned Subsidiary of Nectar Biopharma Private Limited on August 16, 2018. Pursuant to the Scheme of Arrangement approved by the NCLT, Special Bench, Mumbai vide its order dated April 29, 2020, the Specified Undertaking (as defined in the Scheme of Arrangement) was demerged from Nectar Biopharma Private Limited and vested into the Company. Consequently, 1 equity share of face value Rs.10 each of the Company was issued to each shareholders of Nectar Biopharma Private Limited for every 1 equity shares of face value Rs.10 each, held by them in Nectar Biopharma Private Limited as on the record date, i.e. June 9, 2020.Major Events and Milestones :2016- Online launch of Dr. Trust Brand.2017- Launched Dr. Physio brand in electric massager categories and Trumom brand in mother and child care categories.- Started three flex centres in Punjab, Karnataka and Uttar Pradesh.2018- The Company became the wholly owned subsidiary of Nectar Biopharma Private Limited.- Added three flex centres in Chandigarh, Telangana and Maharashtra.- Secured warehouse drug license.2020- Transfer and vesting of Specified Undertaking (as defined under the Scheme) from Nectar Biopharma Private Limited to the Company pursuant to the Scheme of Arrangement.
The Company was incorporated as `Nureca Private Limited', as a private limited company, under the Companies Act, 2013 on November 2, 2016 and a certificate of incorporation was issued by Registrar of Companies, Central Registration Centre, at Delhi. The registered office of the Company was changed from Delhi to Mumbai, Maharashtra, pursuant to certificate of registration of regional director order dated January 8, 2019 for change of state issued by the RoC with effect from February 8, 2019. Upon to conversion into a public limited company pursuant to a special resolution passed in the extra ordinary general meeting of the shareholders of the Company held on June 19, 2020, the name of the Company was changed to the present name `Nureca Limited' and a fresh certificate of incorporation was issued by the RoC on July 8, 2020.The Company became a wholly owned Subsidiary of Nectar Biopharma Private Limited on August 16, 2018. Pursuant to the Scheme of Arrangement approved by the NCLT, Special Bench, Mumbai vide its order dated April 29, 2020, the Specified Undertaking (as defined in the Scheme of Arrangement) was demerged from Nectar Biopharma Private Limited and vested into the Company. Consequently, 1 equity share of face value Rs.10 each of the Company was issued to each shareholders of Nectar Biopharma Private Limited for every 1 equity shares of face value Rs.10 each, held by them in Nectar Biopharma Private Limited as on the record date, i.e. June 9, 2020.Major Events and Milestones :2016- Online launch of Dr. Trust Brand.2017- Launched Dr. Physio brand in electric massager categories and Trumom brand in mother and child care categories.- Started three flex centres in Punjab, Karnataka and Uttar Pradesh.2018- The Company became the wholly owned subsidiary of Nectar Biopharma Private Limited.- Added three flex centres in Chandigarh, Telangana and Maharashtra.- Secured warehouse drug license.2020- Transfer and vesting of Specified Undertaking (as defined under the Scheme) from Nectar Biopharma Private Limited to the Company pursuant to the Scheme of Arrangement.
Read More
Parent Organisation
Nureca Ltd.
Founded
02/11/2016
Managing Director
Mr.Saurabh Goyal
NSE Symbol
NURECABE
FAQ
The current price of Nureca Ltd is ₹ 251.22.
The 52-week high for Nureca Ltd is ₹ 251.22 and the 52-week low is ₹ 247.00.
The market capitalization of Nureca Ltd is currently ₹ 251.22. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Nureca Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Nureca Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Nureca Ltd shares.
The CEO of Nureca Ltd is Mr.Saurabh Goyal, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
